Dm Swastik Auxilaries And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2006
- Open Charges ₹ 9.80 M
About Dm Swastik Auxilaries And Chemicals
Dm Swastik Auxilaries And Chemicals Private Limited (DSAACPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 January 2004 and has a history of 21 years and one month. Its registered office is in Raigarh, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2006. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.80 M.
Neeta Mehta and Bharat Mehta serve as directors at the Company.
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24114MH2004PTC143855
- Company No.
143855
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 2004
- Date of AGM
30 Sep 2006
- Date of Balance Sheet
31 Mar 2006
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Dm Swastik Auxilaries And Chemicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeta Mehta  | Director | 02-Dec-2004 | Current |
| Bharat Mehta | Director | 05-Jan-2004 | Current |
Financial Performance of Dm Swastik Auxilaries And Chemicals.
Enhance accessibility to Dm Swastik Auxilaries And Chemicals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dm Swastik Auxilaries And Chemicals?
Unlock access to Dm Swastik Auxilaries And Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹9.80 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of Hyderabad : 0.98 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jul 2006 | State Bank Of Hyderabad | ₹9.80 M | Open |
How Many Employees Work at Dm Swastik Auxilaries And Chemicals?
Unlock and access historical data on people associated with Dm Swastik Auxilaries And Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dm Swastik Auxilaries And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dm Swastik Auxilaries And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.